3rd Quarter - Report

DALRYMPLE & ASSOCIATES, LLC for EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)

Firm
Client
Income
$63,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.

LobbyistCovered position, as disclosed
DONALD DALRYMPLE Principal

Contacted: Ballistic Missile Defense Organization; Homeland Security, Dept of (DHS); Defense Threat Reduction Agency (DTRA); SENATE; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Army, Dept of (Other); Food & Drug Administration (FDA); White House Office; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES

Homeland Security HOM

Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.

LobbyistCovered position, as disclosed
DONALD DALRYMPLE Principal

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE; Defense Threat Reduction Agency (DTRA); White House Office; Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Homeland Security, Dept of (DHS); Army, Dept of (Other); Ballistic Missile Defense Organization

Medical/Disease Research/Clinical Labs MED

Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.

LobbyistCovered position, as disclosed
DONALD DALRYMPLE Principal

Contacted: Natl Institutes of Health (NIH); Ballistic Missile Defense Organization; Defense, Dept of (DOD); Defense Threat Reduction Agency (DTRA); Army, Dept of (Other); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); White House Office; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.